 |
| MAY
7, 2025 |
| Covering
Life Sciences Drugs, Diagnostics, Devices,
Digital Health |
|
|
|
* may need subscription to view |
 |
| Boston's
most flexible contract vivarium
lab space: Start with a few study
cages and grow. |
|
Learn More
→ |
|
|
- Akamis Bio: Broadens Leadership Team With
Key Executive Appointments More
- Atea Pharmaceuticals: Full Results From
Phase 2 Study of Regimen of Bemnifosbuvir and
Ruzasvir for Treatment of Hepatitis C Virus
(HCV) Presented at EASL Congress 2025 More
- Axena Health: New Budget Impact Model
Published in the Journal of Medical Economics
Highlights Significant Health Plan Cost
Savings With the Leva Pelvic Health System More
- Beacon Therapeutics: Positive Phase 2
Interim 6-Month Data From DAWN Trial of
Laru-zova in Patients With X-linked
Retinitis Pigmentosa (XLRP) at ARVO 2025 More
More
- Benchling and Moderna: Collaborate on
AI-Driven Research More
- Charles River Laboratories: Governance
Updates and Strategic Review to Enhance
Long-Term Stockholder Value More
- Delve Bio: New Data Show Metagenomic
Platform Accurately Identifies Viruses and
Their Subtypes With a Single Test More
- Invaio Sciences: Appoints Magalie
Guilhabert as Chief Science Officer More
- MetaVia: Presents Data on DA-1241, a GPR119
Agonist, Demonstrating Both Hepatoprotective
and Glucose-Regulating Effects in Patients
With Presumed MASH, at the EASL Congress 2025
More
- Ora: Strengthens Global Client Experience
with Appointment of Henry Gerock III as
General Counsel More
- Orogen Therapeutics: Expansion of Board With
Biopharma Leaders Mikael Dolsten and Dieter
Weinand as Independent Non-Executive Directors
More
- PAQ Therapeutics: Appoints Andrew
Krivoshik, MD, PhD, as Chief Medical
Officer, Announces Addition of Eric Rubin,
MD, and Piro Lito MD, PhD, to Advisory Board
More
- ViVerita Therapeutics: Research
Collaboration With Boehringer Ingelheim to
Accelerate Discovery of Novel Cancer Targets More
- Volta Labs and Hartwig Medical Foundation:
Collaborate to Advance Oncological Discoveries
With the Callisto Sample Prep System More
|
|
 |
Strategic
CFO Services for Scaling Biotech
Startups
Explore how biotech startups can
leverage fractional CFO services
to scale efficiently |
|
Learn More
→ |
|
|
- Adicet Bio: First Quarter 2025 Financial
Results and Provides Business Updates More
- Apellis Pharmaceuticals: First Quarter 2025
Financial Results More
- Azenta: Second Quarter Results for Fiscal
2025, Ended March 31, 2025 More
- Bruker: First Quarter 2025 Financial Results
More
- C4 Therapeutics: First Quarter 2025
Financial Results and Recent Business
Highlights More
- Charles River Laboratories:
First-Quarter 2025 Results More
- CRISPR Therapeutics: First Quarter 2025
Financial Results and Announces Positive
Top-Line Data from Phase 1 Clinical Trial of
CTX310 Targeting ANGPTL3 More
More*
- Curis: First Quarter 2025 Business Update More
- Disc Medicine: First Quarter 2025 Financial
Results and Provides Business Update More
- EyePoint: First Quarter 2025 Financial
Results and Highlights Recent Corporate
Developments More
- Ginkgo Bioworks: First Quarter 2025
Financial Results More
- Intellia Therapeutics: Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- Ironwood Pharmaceuticals: First Quarter 2025
Results More
- Keros Therapeutics: Recent First Quarter
2025 Financial Results More
- More on Mersana Making Emi-Le the One,
Laying Off 55% of Staff to Narrow Focus to
B7-H4 ADC More
- More on Vertex Pausing Moderna-Partnered
Cystic Fibrosis Trial, Taking $379M Hit Tied
to Separate Program More
More*
More*
More*
- PAQ Therapeutics: $39 Million Series B
Financing and Initiates Phase 1 Trial to
Advance Novel Approach Addressing KRAS-Driven
Cancers With High Unmet Need More
- Rhythm Pharmaceuticals: First Quarter 2025
Financial Results and Business Update More
- Sarepta Therapeutics: First Quarter 2025
Financial Results and Recent Corporate
Developments More
More*
- Scholar Rock: New Employee Inducement Grants
Under Nasdaq Listing Rule 5635(c)(4) More
- Seres Therapeutics: First Quarter 2025
Financial Results and Provides Business
Updates More
- Voyager: First Quarter 2025 Financial and
Operating Results More
More
|
|
|
- C4 Therapeutics Halts BRAF Degrader Work to
Save Cash for Cemsidomide More
- Harvard Researcher Op-Ed: Cutting Science
Will Cause Outsized Pain to Mass. Economy More*
More
- Harvard: Tracking Precisely How Learning,
Memories are Formed More
- More on Aldeyra Planning to File Reproxalap
Again With New Dry Eye Symptom Data More*
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems More
- OPPORTUNITY: West Coast Business Development
Director More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
